This content is machine translated From chemotherapy to immunotherapy Current system therapy in metastatic non-small cell lung cancer. Detailed molecular diagnosis is now mandatory for non-small cell lung cancer (NSCLC). In the presence of a driver mutation, the corresponding tyrosine kinase inhibitor should be used in the first…
View Post 8 min This content is machine translated Inhalation allergies An “epidemic” affecting a good third of the population Respiratory allergies, especially allergic rhinoconjunctivitis, are very common. They primarily affect the 10-30 age group, but often limit the quality of life much more sensitively in older patients. The main…
View Post 6 min This content is machine translated Interventional treatment of pulmonary embolism Early risk stratification is crucial In patients with suspected pulmonary embolism, risk stratification is important because it guides all subsequent therapeutic decisions. High-risk patients with hemodynamic instability must be identified promptly so that systemic thrombolytic…
View Post 6 min This content is machine translated Pulmonary arterial hypertension New drugs reduce morbidity and mortality Treatment of pulmonary arterial hypertension (PAH) includes nonspecific measures (basic therapy) and specific drugs (selective pulmonary vasodilators). An extended basic therapy, including oral anticoagulation, rhythm control, rehabilitation measures and psychosocial…
View Post 2 min This content is machine translated Non-small cell lung cancer Swiss approval of nivolumab As of November 30, 2015, nivolumab (Opdivo®) has been approved for locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy (regardless of histological subtype). This takes into…
View Post 8 min This content is machine translated Acute pulmonary embolism The role of surgery Pulmonary embolectomy has become an important therapeutic option in patients with acute massive pulmonary embolism with present signs of right ventricular strain when the indication is carefully and interdisciplinary (cardiac…
View Post 6 min This content is machine translated Asthma and sport What do asthmatics need to keep in mind when exercising? The number of top athletes using anti-asthma drugs is high, according to various surveys. This may indicate a particular relationship between physical activity and respiratory disease. Is exercise healthy for…
View Post 6 min This content is machine translated European Lung Cancer Conference Mutation analysis is crucial for the choice of therapy Three interesting studies were presented at the European Lung Cancer Conference in Geneva. Two were dedicated to the group of NSCLC patients with an EGFR-activating mutation. Can erlotinib neoadjuvant achieve…
View Post 5 min This content is machine translated COPD and emphysema therapy What can the family doctor do and when does the patient need to see a pulmonologist? At the Update Refresher, one presentation was dedicated to COPD and emphysema. It was shown which questions should already be clarified in the family practice and how the patient can…
View Post 3 min This content is machine translated New guidelines for acute pulmonary embolism Close monitoring in patients at intermediate risk of mortality. The ESC issued new recommendations on the diagnosis and management of acute pulmonary embolism toward the end of last year [1]. The most relevant innovations compared with the 2008 version…
View Post 2 min This content is machine translated Non-small cell lung cancer CheckMate 057 with promising results Patients with advanced non-squamous type non-small cell lung cancer (NSCLC) benefit from nivolumab after failed platinum-containing chemotherapy. This is the conclusion of the CheckMate 057 study. The tested substance was…
